ProQR Therapeutics N.V. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.15M0.42M0.05M0.20M2.31M7.01M-1.21M6.19M1.58M3.67M7.05M20.20M
Gross Profit 0.15M0.42M0.05M0.20M2.31M7.01M-1.21M6.19M1.58M3.67M7.05M20.20M
Operating items
Depreciation & Amortization - Total 0.03M0.00M0.00M0.00M0.00M0.00M2.30M2.69M2.76M2.57M2.72M2.95M
Research & Development -3.41M-13.65M0.00M0.00M35.18M34.87M52.07M43.54M49.96M51.90M27.20M38.85M
Share-based Compensation (IS) 0.05M0.86M1.35M2.72M
Selling, General & Administrative -1.04M-8.65M7.59M10.49M12.24M14.81M14.43M15.63M20.55M19.03M17.56M14.60M
Other Operating Expenses -0.03M-0.00M25.99M35.34M-0.00M-0.00M-2.30M-2.69M-2.76M-2.57M-2.72M-2.95M
Operating Expenses -4.46M-22.30M33.59M45.83M47.42M49.68M66.50M59.17M70.52M70.93M44.77M53.45M
Operating Income -29.99M-43.81M-45.74M-42.87M-64.33M-48.37M-67.70M-66.48M-34.46M-32.56M
EBIT -4.32M-16.12M-29.99M-43.81M-45.74M-42.87M-64.33M-48.37M-67.70M-66.48M-34.46M-32.56M
Non-operating items
Interest & Investment Income -0.02M5.76M-0.01M-0.00M0.00M-0.94M1.66M0.36M1.79M4.96M2.80M3.47M
Other Non Operating Income 6.74M0.82M-3.01M-0.20M0.81M-2.27M
Non Operating Income 6.85M0.52M-3.59M-0.94M0.45M-4.24M
Net income details
EBT -4.32M-16.12M-23.14M-43.29M-49.32M-43.81M-63.40M-53.08M-71.81M-65.41M-30.09M-29.88M
Tax Provisions 0.00M0.00M0.15M0.14M0.14M0.10M-0.08M-0.21M
Profit After Tax -4.32M-16.12M-0.02M-43.29M-49.32M-43.81M-63.55M-53.22M-71.95M-65.50M-30.00M-29.67M
Equity Income 0.48M-0.37M-0.26M-0.01M
Investment Income 0.00M-0.02M
Income from Non-Controlling Interests -0.04M-0.23M-0.30M-0.06M-0.07M0.22M0.42M
Income from Continuing Operations -4.32M-16.12M-23.14M-43.29M-49.32M-43.81M-63.55M-53.22M-71.95M-65.50M-30.00M-29.67M
Consolidated Net Income -4.32M-16.12M-23.14M-43.29M-49.32M-43.81M-63.55M-53.22M-71.95M-65.50M-30.00M-29.67M
Income towards Parent Company -4.32M-16.12M-23.14M-43.29M-49.28M-43.58M-63.25M-53.17M-71.88M-65.73M-30.42M-29.67M
Net Income towards Common Stockholders -4.32M-16.12M-23.14M-43.29M-49.28M-43.58M-63.25M-53.17M-71.88M-65.73M-30.42M-29.67M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) 0.00M0.00M0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 20.96M20.96M23.34M23.35M23.35M31.92M43.15M54.08M74.86M74.87M84.25M84.25M
Shares Outstanding (Diluted Average) 73.09M87.63M91.99M
EBITDA -4.29M-16.12M0.00M-0.02M0.17M-0.03M0.05M-53.61M-72.26M-63.91M-31.74M-29.61M
Tax Rate 0.28%0.70%